| scholarly article | Q13442814 |
| P50 | author | Uzoma A Anele | Q38325624 |
| P2093 | author name string | James F Casella | |
| Arthur L Burnett | |||
| Irene N Trueheart | |||
| John J Strouse | |||
| P2860 | cites work | Priapism and impotence in homozygous sickle cell disease | Q72621784 |
| Sildenafil citrate-restored eNOS and PDE5 regulation in sickle cell mouse penis prevents priapism via control of oxidative/nitrosative stress | Q21559608 | ||
| Sustained nitric oxide (NO)-releasing compound reverses dysregulated NO signal transduction in priapism | Q33713601 | ||
| Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism | Q33818229 | ||
| American Urological Association Guideline On The Management of Priapism | Q34264094 | ||
| Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism | Q34567470 | ||
| Feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism | Q34572496 | ||
| Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis | Q34581578 | ||
| Targeting NADPH oxidase decreases oxidative stress in the transgenic sickle cell mouse penis | Q36213625 | ||
| Priapism: new concepts in the pathophysiology and new treatment strategies | Q36628795 | ||
| Sickle cell disease status and outcomes of African-American men presenting with priapism | Q37099057 | ||
| Systematic review of the Hawthorne effect: new concepts are needed to study research participation effects | Q37671448 | ||
| New insights into the pathophysiology of sickle cell disease-associated priapism | Q37873572 | ||
| Priapism: new concepts in medical and surgical management | Q37881320 | ||
| Sexual health outcomes improvement in sickle cell disease: a matter of health policy? | Q37910310 | ||
| Sildenafil promotes eNOS activation and inhibits NADPH oxidase in the transgenic sickle cell mouse penis | Q39290264 | ||
| A prospective diary study of stuttering priapism in adolescents and young men with sickle cell anemia: report of an international randomized control trial--the priapism in sickle cell study | Q39810322 | ||
| Priapism in sickle-cell disease; incidence, risk factors and complications - an international multicentre study | Q40569858 | ||
| Molecular analysis of erection regulatory factors in sickle cell disease associated priapism in the human penis | Q41826806 | ||
| Experimental priapism is associated with increased oxidative stress and activation of protein degradation pathways in corporal tissue. | Q42696988 | ||
| Low-flow priapism: risk factors for erectile dysfunction | Q45713780 | ||
| Erection capability is potentiated by long-term sildenafil treatment: role of blood flow-induced endothelial nitric-oxide synthase phosphorylation | Q46455423 | ||
| The physical, social and psychological impact of priapism on adult males with sickle cell disorder. | Q50666182 | ||
| Report of the American Foundation for Urologic Disease (AFUD) Thought Leader Panel for evaluation and treatment of priapism. | Q52048788 | ||
| Priapism associated with the sickle cell hemoglobinopathies: prevalence, natural history and sequelae | Q68175066 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | sickle-cell disease | Q185034 |
| P304 | page(s) | 664-668 | |
| P577 | publication date | 2014-03-25 | |
| P1433 | published in | American Journal of Medicine | Q2842959 |
| P1476 | title | Randomized controlled trial of sildenafil for preventing recurrent ischemic priapism in sickle cell disease | |
| P478 | volume | 127 |
| Q28086979 | 2015 Clinical trials update in sickle cell anemia |
| Q38333659 | A primer on clinical trial design |
| Q39327895 | Advances in the understanding of priapism |
| Q26775925 | Clinical and preclinical treatment of urologic diseases with phosphodiesterase isoenzymes 5 inhibitors: an update |
| Q40852821 | Erectile dysfunction after sickle cell disease-associated recurrent ischemic priapism: profile and risk factors |
| Q39025090 | How I treat priapism |
| Q35034032 | Management of sickle cell disease: a review for physician education in Nigeria (sub-saharan Africa). |
| Q49374657 | Molecular Profile of Priapism Associated with Low Nitric Oxide Bioavailability. |
| Q27010069 | Molecular pathophysiology of priapism: emerging targets |
| Q38610620 | Nitrergic Mechanisms for Management of Recurrent Priapism |
| Q38814652 | Pediatric sickle cell disease: past successes and future challenges |
| Q35779533 | Priapism Impact Profile Questionnaire: Development and Initial Validation |
| Q34852524 | Sickle cell disease: a neglected chronic disease of increasing global health importance |
| Q36144285 | Subacute Hemolysis in Sickle Cell Mice Causes Priapism Secondary to NO Imbalance and PDE5 Dysregulation |
| Q90086490 | THE SCIENCE AND PRACTICE OF ERECTION PHYSIOLOGY: STORY OF A REVOLUTIONARY GASEOUS MOLECULE |
| Q46876025 | Treatments for priapism in boys and men with sickle cell disease. |
| Q89391541 | [Side effects of erectile dysfunction drug treatment] |
Search more.